CAPTRUST FINANCIAL ADVISORS - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$4,0000.0%1,994
+31.9%
0.00%
Q1 2022$4,0000.0%1,512
+83.1%
0.00%
Q4 2021$4,0000.0%8260.0%0.00%
Q3 2021$4,000
-33.3%
8260.0%0.00%
Q2 2021$6,0000.0%8260.0%0.00%
Q1 2021$6,000
+20.0%
826
+3.2%
0.00%
Q4 2020$5,000
+25.0%
8000.0%0.00%
Q3 2020$4,0000.0%8000.0%0.00%
Q2 2020$4,0008000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$16,279,0002.44%
Abingworth LLP 1,041,131$6,517,0002.23%
Telemetry Investments, L.L.C. 194,789$1,219,0002.06%
AIGH Capital Management LLC 749,608$4,692,0001.91%
Trellus Management Company, LLC 340,000$2,128,0001.76%
Bruce & Co., Inc. 929,312$5,817,0001.12%
Worth Venture Partners, LLC 191,093$1,196,0000.95%
GENERAL AMERICAN INVESTORS CO INC 1,000,751$6,265,0000.62%
Weil Company, Inc. 104,907$657,0000.39%
NEXPOINT ASSET MANAGEMENT, L.P. 140,020$877,0000.29%
View complete list of PARATEK PHARMACEUTICALS INC shareholders